Abstract
Although some algorithms are defined for the treatment of advanced hepatocellular carcinoma (HCC), the expected survival cannot be prolonged as it is intended. Treatment options for this group of patients are limited. Radioembolization with yttrium-90 (Y-90) microspheres is a new treatment modality, which has also been used in advanced HCC patients. In this study, the authors aimed to assess the efficiency of radioembolization with Y-90 microspheres and evaluate prognostic factors that influence the survival in HCC patients. The authors retrospectively evaluated data of 29 HCC patients who had radioembolization with Y-90 resin or glass microspheres between May 2009 and January 2014. Patient survival was evaluated by using the Kaplan-Meier method. Subgroup comparisons in terms of age, sex, prior treatment status before radioembolization, tumor burden, time between HCC diagnosis and radioembolization, alpha fetoprotein (AFP) level before radioembolization, presence of portal vein thrombosis (PVT), hepatopulmonary shunt ratio, extrahepatic disease burden, multifocality, bilaterality, Eastern Cooperative Oncology Group (ECOG), Child-Pugh, and Barcelona Clinic Liver Cancer (BCLC) status were performed to evaluate prognostic factors ...Continue Reading
References
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ghassan K Abou-AlfaLeonard B Saltz
Nov 22, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Laura M KulikRiad Salem
Feb 9, 2008·Cancer·Bruno SangroJose I Bilbao
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Sep 22, 2009·Gastroenterology·Riad SalemLaura Kulik
Jan 9, 2010·International Journal of Radiation Oncology, Biology, Physics·Mercedes IñarrairaeguiBruno Sangro
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S JelicUNKNOWN ESMO Guidelines Working Group
Jul 6, 2010·Journal of Vascular and Interventional Radiology : JVIR·Mercedes IñarrairaeguiBruno Sangro
Aug 10, 2010·Journal of Vascular and Interventional Radiology : JVIR·Andrea Lan TsaiBert H O'Neil
Nov 3, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Philip HilgardGerald Antoch
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
May 28, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bruno SangroUNKNOWN European Network on Radioembolization with Yttrium-90 Resin Microspheres (ENRY)
Jul 28, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Bieke LambertLuc Defreyne
Aug 6, 2011·Journal of Hepatology·Bruno SangroJose I Bilbao
Dec 12, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Belen Gil-AlzugarayBruno Sangro
May 8, 2013·Cancer Biotherapy & Radiopharmaceuticals·Cuneyt TurkmenIsik Adalet
Jul 6, 2014·BMC Surgery·Adriana ToroIsidoro Di Carlo
Citations
Jan 19, 2016·Frontiers in Oncology·Andrew GabrielsonKeith Unger
Mar 5, 2016·Nuclear Medicine and Molecular Imaging·Seunghong RheeJae-Gol Choe
Aug 28, 2016·Journal of Vascular and Interventional Radiology : JVIR·Maureen P Kohi
Dec 3, 2016·European Journal of Radiology·Qiu-Song LiuYan-Hao Li
Jun 15, 2018·Nuclear Medicine Communications·Luca FilippiOreste Bagni
Jul 28, 2019·Clinical Nuclear Medicine·Serkan KuyumcuCuneyt Turkmen
Sep 14, 2016·World Journal of Gastroenterology : WJG·Stephen L ChanKenneth S H Chok
Sep 1, 2016·Oncotarget·Carla RognoniVincenzo Mazzaferro
Aug 3, 2019·Cancers·Pedro ViveirosDevalingam Mahalingam
May 14, 2021·BMC Gastroenterology·Nguyen Van ThaiHyun Woong Lee